(15 days)
No
The device description details a laser system with a microprocessor-based controller for parameter selection, but there is no mention of AI or ML capabilities for image processing, data analysis, or automated decision-making. The "Mentions AI, DNN, or ML" section is explicitly marked as "Not Found".
Yes
The device is described as being "intended for the coagulation and haemostasis of vascular lesions and the removal and permanent reduction of unwanted hair," which are therapeutic applications.
No
The device description focuses on its therapeutic uses (coagulation and haemostasis of vascular lesions, hair removal) and does not mention any diagnostic capabilities.
No
The device description clearly outlines multiple hardware components including a laser system, power supply, cooling system, optical delivery system, and a handpiece. While it mentions a microprocessor-based controller, this is part of a larger hardware system, not a standalone software device.
Based on the provided information, the DEPILASE YAG LASE PLUS Laser System is not an IVD (In Vitro Diagnostic) device.
Here's why:
- Intended Use: The intended use clearly states the device is for "coagulation and haemostasis of vascular lesions and the removal and permanent reduction of unwanted hair." These are therapeutic and aesthetic procedures performed directly on the patient's body.
- Device Description: The description details a laser system that delivers energy to the patient via an optical fiber and handpiece. This is consistent with a device used for external treatment.
- Lack of IVD Characteristics: IVD devices are designed to examine specimens (like blood, urine, tissue) in vitro (outside the body) to provide information for diagnosis, monitoring, or screening. The provided information does not mention any analysis of biological samples.
Therefore, the DEPILASE YAG LASE PLUS Laser System is a therapeutic/aesthetic medical device, not an IVD.
N/A
Intended Use / Indications for Use
The DEPILASE YAG LASE PLUS Laser System is intended for the coagulation and haemostasis of vascular lesions and the removal and permanent reduction of unwanted hair in Fitzpatrick skin types I -VI, including suntanned skin types.
Product codes
GEX
Device Description
The DEPILASE YAG LASE PLUS Laser System is based on Nd: YAG laser technology. Within the system, an optical cavity contains the Nd: YAG crystal, which is activated by means of the use of a flashlamp. After the cavity, a red diode aiming beam is reflected onto a coaxial beam path using a beamsplitter assembly. The combined therapeutic and aiming beams are guided down an optical fibre delivery system to a focusing handpiece. The laser is used in a non-contact mode.
The DEPILASE YAG LASE PLUS Laser System is designed with 5 major sub-systems:
- a) A high voltage power supply which converts and rectifies the a.c. mains current to provide regulated power for the flashlamp simmer current and main triggering pulse.
- b) A cooling system consisting of an internal water flow circuit together with water to air heat exchanger.
- c) An Nd: YAG laser rod, capable of generating optical pulses at a frequency up to 3 Hz
- d) An optical delivery system, interfacing the energy from the laser to the patient via an optical fibre and focusing handpiece.
- e) The microprocessor based controller which regulates the functions of the laser and allows parameter selection by the user.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.
(a)
Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
(b)
Classification. (1) Class II.(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.
0
020463 1/2
K 20 16 7
Appendix E
510 (k) Summary
FEB 2 7 2002
- General Information: 1.
・・
| Company: | Depilase Group Ltd
One Canada Square
Canary Wharf
London E14 5DY
United Kingdom |
|--------------------|---------------------------------------------------------------------------------------------|
| Contact Person: | Dr. Mario Luca Russo |
| Preparation: | 12-01-01 |
| Device Trade Name: | DEPILASE YAG LASER PLUS Laser System |
| Common Name: | Long Pulsed Nd:YAG Surgical, Powered, Laser
79-GEX
21 CFR 878-48 |
I. Description
The DEPILASE YAG LASE PLUS Laser System is based on Nd: YAG laser technology. Within the system, an optical cavity contains the Nd: YAG crystal, which is activated by means of the use of a flashlamp. After the cavity, a red diode aiming beam is reflected onto a coaxial beam path using a beamsplitter assembly. The combined therapeutic and aiming beams are guided down an optical fibre delivery system to a focusing handpiece. The laser is used in a non-contact mode.
The DEPILASE YAG LASE PLUS Laser System is designed with 5 major sub-systems:
- a) A high voltage power supply which converts and rectifies the a.c. mains current to provide regulated power for the flashlamp simmer current and main triggering pulse.
- b) A cooling system consisting of an internal water flow circuit together with water to air heat exchanger.
- c) An Nd: YAG laser rod, capable of generating optical pulses at a frequency up to 3 Hz
- d) An optical delivery system, interfacing the energy from the laser to the patient via an optical fibre and focusing handpiece.
- e) The microprocessor based controller which regulates the functions of the laser and allows parameter selection by the user.
1
$$
\infty \approx \infty \quad \text{s} \ll \text{p} \text{Q} \text{>}
$$
The DEPILASE YAG LASE PLUS Laser System is indicated for the coagulation and haemostasis of vascular lesions and the removal and permanent reduction of unwanted hair in Fitzpatrick skin types I – VI, including suntanned skin types.
III. Summary of Substantial Equivalence
Depilase believes that its DEPILASE YAG LASE PLUS Laser System is substantially equivalent to the Laserscope Lyra (K990718), and Altus Medical Aesthetic CoolGlide (K991798) Nd: YAG lasers, previously cleared for both the coagulation and haemostasis of vascular lesions and the removal and permanent reduction of unwanted hair in Fitzpatrick skin types I – VI, including suntanned skin types.
They therefore have the same Intended Use as the DEPILASE YAG LASE PLUS Laser System.
Technologically, the predicate devices have identical characteristics to the DEPILASE YAG LASE PLUS Laser System, all comprising a flashlamp pumped Nd: YAG laser rod generating light at a wavelength of 1064nm, which is subsequently delivered to the patient via an optical fibre delivery system and focusing handpiece.
The DEPILASE YAG LASE PLUS Laser System output characteristics are very similar to those of predicate devices.
All lasers are microprocessor controlled devices.
All lasers utilize Class I aiming beams which pose no hazard to the user.
All systems utilize an internal closed loop water-air heat exchange circuit for optimal thermal control of the laser cavity.
The risk and benefits of the DEPILASE Y AG LASE PLUS Laser System are comparable to the predicate devices when used for similar clinical applications.
It is therefore believed that there are no new questions of Safety or Effectiveness raised by the introduction of this device.
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized depiction of a bird or eagle in flight, rendered in black lines. The bird is enclosed within a circular border, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged around the upper portion of the circle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
FEB 2 7 2002
Depilase Group Ltd. c/o Ms. Pamela Gwynn Engineering Team Leader Underwriters Laboratories, Inc. 12 Laboratory Drive, P.O. Box 13995 Research Triangle Park, North Carolina 27709
Re: K020463
Trade/Device Name: DEPILASE YAG LASE PLUS Laser System Regulation Number: 878.4810 Regulation Name: Laser surgical instrument for use in general and plastic surgery and in dermatology Regulatory Class: II Product Code: GEX Dated: February 3, 2002 Received: February 12, 2002
Dear Ms. Gwynn:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
3
Page 2 – Ms. Pamela Gwynn
This letter will allow you to begin marketing your device as described in your Section 510(k) I mis icter will anow you to ough maing of substantial equivalence of your device to a legally premails in the motions of the a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and If you desire specific advice for you in vitro diagnostic devices), please contact the Office of additionally 21 Of IC For 8659. Additionally, for questions on the promotion and advertising of Comphance at (301) 591-1637. Heater Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). regulation chitities, "Nilocraning of esponsibilities under the Act may be obtained from the Oincl general information of your mational and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
R. Mark N. Millman
Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
APPENDIX F
INDICATIONS FOR USE STATEMENT
K020463 510 (K) Number (if known):
Device Name:
DEPILASE YAG LASE PLUS LASER SYSTEM
Indications For Use:
The DEPILASE YAG LASE PLUS Laser System is intended for the coagulation and haemostasis of vascular lesions and the removal and permanent reduction of unwanted hair in Fitzpatrick skin types I -VI, including suntanned skin types.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
for
(Division Sign-Off)
Division of General, Restorative
and Neurological Devices
510(k) Number K020463
Prescription Use
(per 21 CFR 801.109)
OR Over The Counter Use